This volume will address transdermal and transmucosal drug delivery systems. Both of these systems continue to be of high interest for the delivery of proteins and peptides due to high permeability of mucosal tissue and adaptability of dermal application.

Download a Flyer (Acrobat Reader required)

Additional Information

The Drug Delivery Series

An Innovative NEW Series of Five Reports, Featuring Primary Research & Global Coverage

Drug delivery is one of the most important drivers in the rapidly changing pharmaceutical industry. Each volume of this new series examines an area of drug delivery singly and in depth. Market opportunities, new technologies and products, shifting alliances and licensing deals, important trends, and forecasts through 2005 are covered in each of the five volumes of the series.

Kalorama’s analysts have taken a unique look at the market today and in the future by calculating not only total market size and growth, but also the relative value of the drug delivery component itself as separate from total pharmaceutical sales. This quantitative analysis is extremely instructive and unique to this series of reports.

Anyone involved in the pharmaceutical industry—drug delivery companies or pharmaceutical manufacturers—can turn to this series to examine competitors, extend product life cycles, and learn more about the plethora of advanced drug delivery systems in development that will suit currently available products.

For each of the major delivery routes, the series covers:

• Market size, segmentation, and growth
• Market drivers, barriers, and trends
• Competitive analysis of companies and products—both current and in development
• Value of drug delivery technology in relation to pharmaceutical products
• Impact of delivery technology on the viability of new biopharmaceuticals
• Implications for pharmaceutical sales and marketing
• Profiles of the major players, including partnerships and alliances
• International directory of companies involved in the segment

Use These Valuable Reports to:

• Define and size your target market
• Capitalize on industry trends
• Reduce the risk of your business investment
• Position yourself against your competition
• Effectively launch new products or enter new markets
• Create successful marketing and sales strategies
• Create highly-targeted marketing messages
• Strengthen brand awareness
• Identify new revenue opportunities
• Empower your sales force with the tools they need to succeed

Scope and Methodology

The market for transdermal/transmucosal drug delivery systems details the types of drug delivery systems and technologies that are being used in 2000, as well as those that may become major market factors by the end of the forecast period. The report describes the industry, its relationship to various healthcare channels, and the trends for the future.

The transdermal/transmucosal drug delivery market is two-fold. First of all, it encompasses drug delivery technology and the revenues earned from licensing that technology. Secondly, it encompasses the pharmaceutical arena as well. Because drug delivery technology is an integral part of sales of pharmaceuticals and drug delivery technology cannot exist without pharmaceuticals, revenues have been reported that include pharmaceutical sales. This is inclusive of the entire market for transdermal/transmucosal drug delivery. This report will provide market data that include the pharmaceutical and drug delivery revenues in total; but also, it will demonstrate the percent of revenues that are attributed solely to drug delivery sales. This will be presented for the entire forecast period from 1996 to 2006.

Related Reports:
Biotechnology Sector
Monoclonal antibodies: 2009 update
Opportunities in Human Embryonic Stem Cell (hESC) Products
Global Stem Cell and Advanced Technologies Market
Scientific Research in Australia - Industry Risk Rating Report
Biotechnology in Australia - Industry Risk Rating Report
Scientific Research & Development in the US - Industry Risk Rating Report
Biotechnology in the US - Industry Risk Rating Report
Biotechnology: Global Industry Guide
Biomarker and Diagnostic Opportunities in Clinical Research for Neurological Diseases